Antibody-Drug Conjugates in Prostate Cancer: Where Are we?

Auteurs : Mjaess G, Aoun F, Rassy E, Diamand R, Albisinni S, Roumeguère T
Année : 2023
Journal : Clin Genitourin Cancer
Volume : 21
Pages : 171-174

Accuracy of elastic fusion biopsy: Comparing prostate cancer detection between targeted and systematic biopsy.

Auteurs : Oderda M, Albisinni S, Benamran D, Calleris G, Ciccariello M, Dematteis A, Diamand R, Descotes JL, Fiard G, Forte V, Giacobbe A, Marquis A, Marra G, Messas A, Muto G, Peltier A, Rius L, Simone G, Roumeguere T, Faletti R, Gontero P
Année : 2023
Journal : Prostate
Volume : 83
Pages : 162-168

Optimizing multiparametric magnetic resonance imaging-targeted biopsy and prostate cancer grading accuracy.

Auteurs : Diamand R, Peltier A, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Albisinni S
Année : 2023
Journal : World J Urol
Volume : 41
Pages : 77-84

Role of the Prostate Imaging Quality PI-QUAL Score for Prostate Magnetic Resonance Image Quality in Pathological Upstaging After Radical Prostatectomy: A Multicentre European Study.

Auteurs : Windisch O, Benamran D, Dariane C, Favre MM, Djouhri M, Chevalier M, Guillaume B, Oderda M, Gatti M, Faletti R, Colinet V, Lefebvre Y, Bodard S, Diamand R, Fiard G
Année : 2023
Journal : Eur Urol Open Sci
Volume : 47
Pages : 94-101

Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining-targeted biopsy.

Auteurs : Diamand R, Peltier A, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Albisinni S
Année : 2023
Journal : Prostate

Understanding biochemical recurrence after radical prostatectomy: trust biology, not a number.

Auteurs : Albisinni S, Diamand R
Année : 2023
Journal : Prostate Cancer Prostatic Dis

Teaching robotic cystectomy: Prospective pilot clinical validation of the ERUS training Curriculum.

Auteurs : Diamand R, DHondt F, Mjaess G, Jabbour T, DellOglio P, Larcher A, Moschini M, Quackels T, Peltier A, Assenmacher G, Wiklund P, Breda A, Turri F, De Groote R, Mottrie A, Roumeguere T, Albisinni S
Année : 2023
Journal : BJU Int

Do perioperative blood transfusions impact oncological outcomes of robot-assisted radical cystectomy with intracorporeal urinary diversion? Results from a large multi-institutional registry.

Auteurs : Sarkis J, Diamand R, Aoun F, Assenmacher G, Assenmacher C, Verhoest G, Holz S, Naudin M, Ploussard G, Mari A, Minervini A, Tay A, Issa R, Roumiguié M, Bajeot AS, Simone G, Anceschi U, Umari P, Sridhar A, Kelly J, Hendricksen K, Einerhand S, Mertens LS, Sanchez-Salas R, Colomer A, Quackels T, Peltier A, Montorsi F, Briganti A, Pradere B, Moschini M, Roumeguère T, Albisinni S
Année : 2023
Journal : Minerva Urol Nephrol
Volume : 75
Pages : 50-58

Urinary microbiota and prostatic diseases: the key for the lock? A systematic review.

Auteurs : Mjaess G, Karam A, Roumeguère T, Diamand R, Aoun F, McVary K, Moul JW, DE Nunzio C, Albisinni S
Année : 2022
Journal : Prostate Cancer Prostatic Dis

[Prostate cancer, androgen deprivation, and risk of COVID-19 infection : A systematic review and meta-analysis].

Auteurs : Manolache NG, Mjaess G, Diamand R, Albisinni S, Roumeguère T
Année : 2022
Journal : Prog Urol
Volume : 32
Pages : 1421-1430

Intra-Cavernosal Injection of Botulinum Toxin in the Treatment of Erectile Dysfunction: a Systematic Review and Meta-Analysis.

Auteurs : Abou Zahr R, Bou Kheir G, Mjaess G, Jabbour T, Chalhoub K, Diamand R, Roumeguère T
Année : 2022
Journal : Urology
Volume : 170
Pages : 5-13

Cost-analysis of robot-assisted radical cystectomy in Europe: A cross-country comparison.

Auteurs : Mjaess G, Diamand R, Aoun F, Assenmacher G, Assenmacher C, Verhoest G, Holz S, Naudin M, Ploussard G, Mari A, Tay A, Issa R, Roumiguié M, Bajeot AS, Umari P, Sridhar A, Kelly J, Hendricksen K, Einerhand S, Mertens LS, Sanchez-Salas R, Gallardo AC, Quackels T, Peltier A, Pradere B, Moschini M, Roumeguère T, Albisinni S
Année : 2022
Journal : Eur J Surg Oncol

Grade group 1 prostate cancer on biopsy: are we still missing aggressive disease in the era of image-directed therapy?

Auteurs : Baboudjian M, Roumiguié M, Peltier A, Oderda M, Barret E, Fromont G, Dariane C, Fiard G, Charvet AL, Gondran-Tellier B, Durand-Labrunie C, Campello PV, Roumeguère T, Diamand R, Diana P, Touzani A, Beauval JB, Daniel L, Rouprêt M, Ruffion A, Ploussard G
Année : 2022
Journal : World J Urol
Volume : 40
Pages : 2423-2429

Prebiopsy (68)Ga-PSMA PET imaging: can we improve the current diagnostic pathway for prostate cancer?

Auteurs : Albisinni S, Sarkis J, Diamand R, DE Nunzio C
Année : 2022
Journal : Prostate Cancer Prostatic Dis

External Validation of Models for Prediction of Side-specific Extracapsular Extension in Prostate Cancer Patients Undergoing Radical Prostatectomy.

Auteurs : Diamand R, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Favre MM, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Peltier A, Albisinni S
Année : 2022
Journal : Eur Urol Focus

Expanding Active Surveillance Criteria for Low- and Intermediate-risk Prostate Cancer: Can We Accurately Predict the Risk of Misclassification for Patients Diagnosed by Multiparametric Magnetic Resonance Imaging-targeted Biopsy?

Auteurs : Diamand R, Albisinni S, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, An Nguyen T, Fournier G, Fiard G, Ploussard G, Peltier A, Roumeguère T
Année : 2022
Journal : Eur Urol Focus

Reply to Bernardo Rocco and Maria Chiara Sighinolfi's Letter to the Editor re: Romain Diamand, Jean-Baptiste Roche, Elena Lievore, et al. External Validation of Models for Prediction of Side-specific Extracapsular Extension in Prostate Cancer Patient

Auteurs : Diamand R, Albisinni S
Année : 2022
Journal : Eur Urol Focus

Optimizing multiparametric magnetic resonance imaging-targeted biopsy and detection of clinically significant prostate cancer: the role of perilesional sampling.

Auteurs : Noujeim JP, Belahsen Y, Lefebvre Y, Lemort M, Deforche M, Sirtaine N, Martin R, Roumeguère T, Peltier A, Diamand R
Année : 2022
Journal : Prostate Cancer Prostatic Dis

Magnetic Resonance Imaging-based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM Classification.

Auteurs : Baboudjian M, Gondran-Tellier B, Touzani A, Martini A, Diamand R, Roche JB, Lacetera V, Beauval JB, Roumeguère T, Simone G, Benamran D, Fourcade A, Fiard G, van den Bergh RCN, Peltier A, Ploussard G
Année : 2022
Journal : Eur Urol Oncol

Oncological outcomes of radical prostatectomy in very high-risk patients according to STAMPEDE criteria: does local treatment alone still have a place in the era of intensified systemic therapies?

Auteurs : Baboudjian M, Touzani A, Martini A, Diamand R, Roche JB, Lacetera V, Beauval JB, Gondran-Tellier B, Roumeguère T, Simone G, Windisch O, Benamran D, Fourcade A, Fiard G, Van Den Bergh RC, Peltier A, Ploussard G
Année : 2022
Journal : Minerva Urol Nephrol